跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,028 条关于
“acquired hypothalamic obesity”
全部
18,028
临床试验
14,350
药物
104
机构
21
资讯
3,553
去年
Setmelanotide Receives Orphan Drug Designation in Japan for Hypothalamic Obesity Treatment
去年
Rhythm Pharmaceuticals' Setmelanotide Shows Breakthrough Results in Rare Hypothalamic Obesity Trial
10个月前
Rhythm Pharmaceuticals Reports Strong Q3 2025 Results with $51.3M IMCIVREE Revenue and December FDA Decision Pending
去年
Rhythm Pharmaceuticals' Imcivree Shows Significant Weight Loss in Phase III Hypothalamic Obesity Trial
去年
Rhythm Pharmaceuticals Announces Positive IMCIVREE® Sales and Pipeline Advancements
8个月前
Rhythm Pharmaceuticals Faces FDA Delay for Setmelanotide in Hypothalamic Obesity as Stock Retreats from 2025 Highs
去年
Rhythm's Imcivree Shows Significant Weight Loss in Patients with Hypothalamic Obesity
去年
Rhythm Pharmaceuticals Regains Global Control of IMCIVREE by Reacquiring Rights in China
去年
Rhythm Pharmaceuticals Reports Strong Q3 2024 Driven by IMCIVREE Sales, Advances Hypothalamic Obesity Program
去年
Aardvark Therapeutics Files for $100M IPO to Advance Novel Hyperphagia Treatment
第 1 页，共 356 页
上一页
下一页
